Professor Simon Dixon BSc (Southampton), MSc (York), PhD (Sheffield)

Professor of Health EconomicsDixon1

HEDS, ScHARR
The University of Sheffield
Regent Court, 30 Regent Street
Sheffield, S1 4DA

Office: 103
ScHARR
West Court
Mappin Street
Sheffield
S1 4DP

Direct telephone: (+44) (0)114 222 0724
General office fax: (+44) (0)114 222 0749

Email: s.dixon@sheffield.ac.uk

ORCiD: 0000-0001-7394-7009

Biography

My work at ScHARR has concentrated around undertaking and developing methods for economic evaluations alongside controlled trials. Whilst the main focus of this work has been pre-hospital and emergency care, I have undertaken evaluations in numerous other areas. A separate stream of work is examining the measurement and valuation of health care benefits. This is focusing on alternatives to, and extensions of, the standard QALY model.

Research interests

  • Public preferences for public health (link to project page under 'Projects').
  • Methods of HTA and reimbursement systems 
  • Measurement and valuation of health care benefits.
  • Economic evaluation.

Teaching Interests

My teaching is concentrated around the methods of economic evaluation which I teaching in various formats on the MSc Health Economics and Decision Modelling, MSc Economics and Health Economics, MSc International Health Technology Assessment, Pricing and Reimbursement and the MBChB.

I am the module coordinator for the Economic Evaluation modules on MSc International Health Technology Assessment, Pricing and Reimbursement.

I am interested in supervising Research Students wishing to develop the methods of economic evaluation and benefit valuation. I am particularly interested in empirical ethics and a more empirically based QALY approach, including the role of sequences and process utility.

I currently supervise, or sit on the supervisory panel for three students; Victoria Brennan, Kinga Lowrie and Sabine Grimm. Their topics relate to the evaluation of an electronic patient questionnaire, evaluation of telehealth and the valuation of innovation in non-pharmaceutical technologies.

PhD Supervision

I am currently supervising the following postgraduate research students:

Genevieve David, who is examining the role of public preferences in alcohol licensing decision making in English local authorities.

Yingpeng Qui, who is exploring methods to supporting the development of National List of Appropriate Health Technology in China.

Naomi Gibbs who is exploring the health economic and equity impacts of alcohol pricing policies in South Africa.

Abu Alshreef who is a NIHR Doctoral Research Fellow, looking at the development of a methodological framework to account for the impact of non-adherence on the cost-effectiveness of prescribed chronic medications.

Chu Chang Ku is researching healthcare seeking behaviour as a link between tuberculosis and socioeconomic factors using hybrid modelling.

Professional Activities

  • Honorary Professor in the Priority Cost Effective Lessons for Systems Strengethening (PRICELESS), School of Public Health, University of Witwatersrand.
  • External Examiner at the University of York for the PG Cert and PG Dip Health Economics for Health Care Professionals; MSc Economic Evaluation for Health Technology Assessment.
  • Academic Committee of the Center for Healthcare Big Data of Tsinghua Center for Statistical Science.
  • Advisory Board for HERU, University of Aberdeen

Current Activities

  • Salivary Cortisone as an Adrenal Insufficiency Test (SCAIT)
  • Take home naloxone In Multicentre Emergency setting feasibility trial (TIME)
  • Increasing uptake of effective self-management education programmes for type 2 diabetes in multi-ethnic primary care settings
  • NIHR Global Health Research Group on Preterm Birth Prevention and Management (PRIME)
  • Development of customised non-invasive ventilation interfaces for children for whom current commercial masks are unavailable or unsuitable to improve ventilation therapies and reduce complications.
  • Female Urgency, Trial of Urodynamics as Routine Evaluation (FUTURE); a superiority randomised clinical trial to evaluate the effectiveness and cost effectiveness of invasive urodynamic investigations in management of women with refractory overactive bladder symptoms

Extended List of Publications

Journal articles